Trials / Completed
CompletedNCT03739788
An Investigational Study to Evaluate Experimental Medication BMS-986165 Given as a Tablet and Solution in Healthy Male Participants
Study to Evaluate the Absolute Bioavailability of BMS-986165 Tablet in Healthy Male Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate BMS-986165 given as a tablet in healthy male participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986165 | Oral administration of tablet and 15-minute intravenous BMS-986165 solution for infusion |
Timeline
- Start date
- 2018-12-05
- Primary completion
- 2019-02-11
- Completion
- 2019-02-11
- First posted
- 2018-11-14
- Last updated
- 2021-02-26
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03739788. Inclusion in this directory is not an endorsement.